1.
|
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 75
Sponsor: NCI
Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: ROLL-GUP-0205-1, UCLA-0507059-01, NCT00336934
|
|
3.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: CCCWFU-97405, CCCWFU 97405, WFU-97405, CCCWFU-BG05-529, NCT00354432
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: ABROIN-MAPS, MAPS, ISRCTN87696430, NCT00632138
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: NCIC 013232, OTT 02-04, CERHO 2002263-01H, NCT00253916
|
|
6.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 0808, NCT00809458
|
|
7.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Under 80
Sponsor: NCI
Protocol IDs: UARIZ-99-0045-01, 99-0045-01, NCT00978718
|
|
8.
|
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NYM # 325, NCT00421902
|
|
9.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMN-2008LS035, UMN-2008LS035, UMN-0803M29541, NCT00769990
|
|
10.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: OSU-2007C0026, 2007C0026, NCT01009736
|
|
11.
|
Phase: Phase II, Phase I
Type: Prevention
Status: Approved-not yet active
Age: 40 to 70
Sponsor: Other
Protocol IDs: PHS 2333.00, 6969, NCT00946309
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SHEBA-06-4232-RW-CTIL, NCT00411853
|
|
13.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: CCCWFU-85106, CCCWFU-IRB00000371, CCCWFU 85106, NCT00499408
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-I-95406, I 95406, NCT00524680
|
|
15.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Germanium, NCT00651417
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4P-07-3, NCT00669656
|
|
17.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 75
Sponsor: NCI
Protocol IDs: UCLA-061109702, 06-11-097-02, NCT00685516
|
|
18.
|
Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 80
Sponsor: NCI, Other
Protocol IDs: MCC 15008, USF#105730, RO1 CA12060-01A1, NCT00596011
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GUP-0205-1X, NCT00731848
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GUP-0205-1XX, NCT00732043
|
|
21.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 to 85
Sponsor: Other
Protocol IDs: M2140, NCT00741364
|
|
22.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0580-B, NCT00744549
|
|
23.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 85
Sponsor: NCI
Protocol IDs: UARIZ-97-0395, UARIZ-HSC-97-57, Watchful Waiting, DAMD17-98-1-8580, 97-0395-01, NCT00752739
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0604-CE, NCT00844792
|
|
25.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: WSU-2007-128, 2007-128, NCT00888654
|
